Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.

Abstract:

:The aim of this study was to assess the anti-tumor effect and mechanisms of cimetidine in N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced bladder carcinogenesis model. Sixty-three male BALB/c mice and 67 male Wister rats were treated with BBN and cimetidine to examine the anti-tumor effect of cimetidine. Immunohistochemistry (IHC) of vascular endothelial growth factor (VEGF), platelet-derived endothelial growth factor (PDECGF), and E-selectin were examined to compare their expression in the tumor tissues. In mice, the tumor growth was reduced by cimetidine (p=0.011). The expression of PDECGF was reduced in the cimetidine-treated group (p=0.016). In rats, treatment of cimetidine reduced tumor growth (p=0.0001). Moreover, the expression of VEGF and PDECGF was reduced (p=0.02 and <0.001, respectively). The expression of E-selectin did not correlate with the tumor growth in either mice or rats. In mice, long-term cimetidine treatment proved very effective for inhibiting the tumor growth, but in rats, BBN after treatment with cimetidine showed the least tumor growth-inhibitory effect. In conclusion, cimetidine may have an inhibitory effect on tumor growth in bladder carcinogenesis via reducing the expression of angiogenesis factors including VEGF and PDECGF.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Chihara Y,Fujimoto K,Miyake M,Hiasa Y,Hirao Y

doi

10.3892/or_00000401

subject

Has Abstract

pub_date

2009-07-01 00:00:00

pages

23-8

issue

1

eissn

1021-335X

issn

1791-2431

journal_volume

22

pub_type

杂志文章
  • Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma.

    abstract::Immunotherapy of cancer offers great promise, however translation into human studies has yielded relatively poor results to date. The concept of combining cancer vaccination with angiogenesis inhibition is appealing, due to favorable safety profile of both approaches, as well as possible biological synergies. Here we ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000555

    authors: Chan RC,Gutierrez B,Ichim TE,Lin F

    更新日期:2009-11-01 00:00:00

  • Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.

    abstract::Previous studies have suggested that certain genetic polymorphisms, specifically the Xeroderma pigmentosum group D (XPD) gene codon 751 and the X-ray repair cross-complementing group 1 (XRCC1) gene codon 399 polymorphisms, were associated with an increased risk of lung cancer, and, in some studies, with a greater risk...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000854

    authors: Gao W,Romkes M,Zhong S,Nukui T,Persad RA,Smith PJ,Branch R,Keohavong P

    更新日期:2010-07-01 00:00:00

  • Effect of wortmannin on the suppression of thermotolerance in tsAF8 cells.

    abstract::Phosphatidylinositol 3 kinases (PI-3 kinases) play a crucial role in the inositol phospholipid signaling pathway. The effect of wortmannin, an inhibitor of PI-3 kinases, on the suppression of thermotolerance development was investigated in the temperature-sensitive cell line tsAF8. When wortmannin was added immediatel...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shibuya K,Kawasaki S,Kuroda M,Takemoto M,Asaumi J,Hiraki Y

    更新日期:2002-01-01 00:00:00

  • Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.

    abstract::Cervical cancer is the second most common gynecological malignancy. The mechanisms of the genesis and progression of cervical cancer are complicated and not thoroughly understood. DEK is reported as an oncogene in various cancers, such as acute myeloid leukemia, bladder cancer, breast cancer and hepatocellular cancer....

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5721

    authors: Xu X,Zou L,Yao Q,Zhang Y,Gan L,Tang L

    更新日期:2017-08-01 00:00:00

  • Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.

    abstract::Ulcerative colitis (UC) is an important risk factor for colorectal cancer (CRC). Histone modifications are one of the epigenetic mechanisms that may have key roles in the carcinogenesis of CRC. At present, there are no studies comparing histone modification patterns of UC and CRC in the literature. Therefore the aim o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4187

    authors: Gerçeker E,Boyacıoglu SO,Kasap E,Baykan A,Yuceyar H,Yıldırım H,Ayhan S,Ellidokuz E,Korkmaz M

    更新日期:2015-10-01 00:00:00

  • Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

    abstract::Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invasion of acute T lymp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7453

    authors: Teng Z,Xu S,Lei Q

    更新日期:2020-02-01 00:00:00

  • Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.

    abstract::Given the important role of CXCR4 in cancer metastasis, microenvironmental factors that modulate CXCR4 may have an impact on the process of tumor expansion. Hypoxia is a common feature of solid tumors and a significant microenvironmental factor that drives aggressive behavior. CXCR4...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2063

    authors: Oh YS,Kim HY,Song IC,Yun HJ,Jo DY,Kim S,Lee HJ

    更新日期:2012-12-01 00:00:00

  • Aberrant expression of class III beta-tubulin in basal cell carcinoma of the skin.

    abstract::Tubulin is a major component of microtubules. Class III beta-tubulin (beta III) is a neuron-associated beta-tubulin isotype and expressed in the normal central and peripheral nervous systems. According to a previous study, beta III is not expressed in normal skin and squamous cell carcinoma. However, its expression ha...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000494

    authors: Ishida M,Kushima R,Okabe H

    更新日期:2009-10-01 00:00:00

  • In vivo evidence for a significant role of folylpolyglutamate synthase in combined chemotherapy with oral fluoropyrimidine, UFT or S-1, and leucovorin.

    abstract::Combined chemotherapy with 5-fluorouracil and leucovorin (LV) has been widely used for the treatment of patients with colorectal cancer. Given that LV effects are attributable to increased levels of reduced folate in cancer cells, we attempted here to show the in vivo role of folylpolyglutamate synthetase (FPGS), whic...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1206

    authors: Tsukioka S,Sakamoto E,Tsujimoto H,Nakagawa F,Saito H,Uchida J,Kiniwa M,Fukushima M

    更新日期:2011-05-01 00:00:00

  • Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes.

    abstract::Adoptive immunotherapy requires the isolation of CD8+ T cells specific for tumor-associated antigens, their expansion in vitro and their transfusion to the patient to mediate a therapeutic effect. MUC1 is an important adenocarcinoma antigen immunogenic for T cells. The MUC1-derived SAPDTRPA (MUC1-8-mer) peptide is a p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4328

    authors: Atzin-Méndez JA,López-González JS,Báez R,Arenas-Del Angel MC,Montaño LF,Silva-Adaya D,Lascurain R,Gorocica P

    更新日期:2016-01-01 00:00:00

  • MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.

    abstract::MicroRNAs (miRNAs) are a class of highly conserved, small endogenous single-strand non-coding RNAs. They are aberrantly expressed in the circulation and tissue of patients with cancer. Therefore, it has been suggested that they may act as key regulators of carcinogenesis. The aim of the present study was to examine th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.2971

    authors: Luo Q,Wei C,Li X,Li J,Chen L,Huang Y,Song H,Li D,Fang L

    更新日期:2014-03-01 00:00:00

  • Hepatitis B virus X protein modifies invasion, proliferation and the inflammatory response in an HTR-8/SVneo cell model.

    abstract::Mother-to-infant transmission of hepatitis B virus (HBV) can occur as an intrauterine, intrapartum or postpartum infection. In the present study, we induced a multifunctional viral regulator of HBV gene products, HBx, and its different fragments to overexpress in a tropho-blast cell line, HTR-8/SVneo. We then identifi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4172

    authors: Cui H,Li QL,Chen J,Na Q,Liu CX

    更新日期:2015-10-01 00:00:00

  • B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.

    abstract::B7-H1 is a co-inhibitory molecule belonging to the B7 family. The B7-H1 protein is only expressed on macrophage lineage of cells in normal tissues, but is overexpressed in most types of tumor. The aberrant expression of cell surface B7-H1 on cancer cells is generally associated with high-risk prognostic factors. The t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2686

    authors: Zhang C,Wang W,Qin X,Xu Y,Huang T,Hao Q,Li W,Wu S,Zhang Y

    更新日期:2013-11-01 00:00:00

  • Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.

    abstract::Notable advances in treatment have been made and increases in the cure rates of pediatric leukemia have been achieved. However, the majority of children with relapsed disease are not expected to survive, with chemotherapy resistance acting as the principal cause of treatment failure. Interaction between leukemic cells...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6808

    authors: Pillozzi S,Bernini A,Spiga O,Lelli B,Petroni G,Bracci L,Niccolai N,Arcangeli A

    更新日期:2019-01-01 00:00:00

  • Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer.

    abstract::Mitochondrial DNA (mtDNA) mutations occur in a variety of human cancers, suggesting a possible role for mitochondrial respiratory functions in tumorigenesis. Recent studies have demonstrated that SDHD, a nuclear gene encoding one of the mitochondrial complex II subunits, acts as a tumor-suppressor for hereditary parag...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Habano W,Sugai T,Nakamura S,Uesugi N,Higuchi T,Terashima M,Horiuchi S

    更新日期:2003-09-01 00:00:00

  • Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.

    abstract::Luteolin was recently demonstrated to suppress tumor growth by interfering with nuclear factor (NF)‑κB activation. As the NF‑κB pathway plays a critical role in muscular atrophy associated with cancer cachexia, we aimed to investigate the potential of luteolin to alleviate cancer‑associated cachexia in a Lewis lung ca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6453

    authors: Chen T,Li B,Xu Y,Meng S,Wang Y,Jiang Y

    更新日期:2018-08-01 00:00:00

  • miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.

    abstract::Accumulating evidence has shown that aberrantly expressed microRNAs (miRNAs) are associated with tumor development and progression. Our previous study found that microRNA-375 (miR-375) was downregulated in colorectal cancer (CRC), but little is known concerning the role of miR-375 and the related mechanism in CRC deve...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4834

    authors: Cui F,Wang S,Lao I,Zhou C,Kong H,Bayaxi N,Li J,Chen Q,Zhu T,Zhu H

    更新日期:2016-07-01 00:00:00

  • Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.

    abstract::Engrailed 2 (EN2) is a member of the homeobox gene family. Many studies suggest that overexpression of EN2 protein may be associated with tumor development, including bladder cancer (BC). However, to date, the mechanisms of how EN2 functions to promote BC progression remain elusive. The present study introduced RNAi t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3858

    authors: Li Y,Liu H,Lai C,Su Z,Heng B,Gao S

    更新日期:2015-05-01 00:00:00

  • Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.

    abstract::Although antiestrogens significantly improve the survival of patients with ER-positive breast cancer, therapeutic resistance remains a major limitation. The combinatorial use of antiestrogen with other therapies was proposed to increase their efficiency and more importantly, to prevent or delay the resistance phenomen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4873

    authors: Maynadier M,Basile I,Gallud A,Gary-Bobo M,Garcia M

    更新日期:2016-08-01 00:00:00

  • Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo.

    abstract::Inhibitor of DNA-binding protein 1 (ID1) is commonly abnormally overexpressed in colorectal cancer (CRC); yet, the functional significance of ID1 in the growth and invasive properties of CRC cells remains largely unclear. The present study investigated the effects of ID1 downregulation on the cell growth and metastati...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3172

    authors: Lai X,Liao J,Lin W,Huang C,Li J,Lin J,Chen Q,Ye Y

    更新日期:2014-07-01 00:00:00

  • Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.

    abstract::The nitrostyrene scaffold was previously identified as a lead target structure for the development of effective compounds targeting Burkitt's lymphoma. The present study aimed to develop these compounds further in haematological malignancies, including chronic lymphocytic leukaemia (CLL). Cellular viability, flow cyto...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7068

    authors: Bright SA,Byrne AJ,Vandenberghe E,Browne PV,Mcelligott AM,Meegan MJ,Williams DC

    更新日期:2019-05-01 00:00:00

  • Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.

    abstract::Emodin (EMO) has been shown to possess pleiotropic anticancer capabilities in many types of cancer, including epithelial ovarian cancer (EOC). Inhibitory efficacy of EMO on EOC invasion and migration was previously observed, however, the underlying mechanisms have not been completely elucidated. The present study is a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4591

    authors: Hu C,Dong T,Li R,Lu J,Wei X,Liu P

    更新日期:2016-04-01 00:00:00

  • Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma.

    abstract::Semaphorin 3A (SEMA3A), a secretory protein, is a founding member of the semaphorin family and functions in both the biological behavior of tumor cells and the modulation of tumor-associated macrophages. However, the role of SEMA3A in hepatocellular carcinoma (HCC) is still not well established. In the present study, ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5616

    authors: Li X,Chen Q,Yin D,Shi S,Yu L,Zhou S,Chen E,Zhou Z,Shi Y,Fan J,Zhou J,Dai Z

    更新日期:2017-06-01 00:00:00

  • Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.

    abstract::The number of new lung cancer cases diagnosed yearly is high, and the mortality rate has not substantially declined. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and adenocarcinoma accounts for the largest proportion of NSCLC. Currently, platinum-based combined chemotherapy, particularly ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5505

    authors: Cheng R,Lu C,Zhang G,Zhang G,Zhao G

    更新日期:2017-04-01 00:00:00

  • Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.

    abstract::hTERTC27, a 27-kDa hTERT C-terminal polypeptide has been demonstrated to cause hTERT-positive HeLa cell apoptosis and inhibits the growth of mouse melanoma. hTERTC27 has been associated with telomere dysfunction, regulation of gene-regulated apoptosis, the cell cycle and activation of natural killer (NK) cells, but it...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1619

    authors: Gong HX,He L,Li XP,Wang YD,Li Y,Huang JJ,Wang Z,Xie D,Kung HF,Peng Y

    更新日期:2012-04-01 00:00:00

  • Pentoxifylline promotes development of murine colon adenocarcinoma-derived metastatic tumors in liver.

    abstract::Pentoxifylline is commonly used in the treatment of peripheral vascular diseases. It improves microcirculatory flow and tissue perfusion. Moreover, pentoxifylline displays some immunomodulatory properties that presumably might affect the anticancer response. Therefore, the aim of the present study was to evaluate the ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Grzela T,Lazarczyk M,Niderla J,Golab J,Lazarczyk MA,Skopinski P

    更新日期:2003-11-01 00:00:00

  • ERK signaling mediates long-term low concentration 3,3'-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: An in vitro and in vivo study.

    abstract::It is well known that crucifers have antitumor effects and 3,3'-diindolylmethane (DIM) is one of the major bioactive components, and the associated molecular mechanisms in a short-term high-dose manner are widely discussed. However, the antitumor effects of DIM in a long-term low-dose manner in nasopharyngeal carcinom...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4428

    authors: Li F,Chen C,Chen SM,Xiao BK,Tao ZZ

    更新日期:2016-02-01 00:00:00

  • Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.

    abstract::Like many other solid tumors, cervical cancer contains a heterogeneous population of cancer cells. Several investigators have identified putative stem cells from solid tumors and cancer cell lines via the capacity to self renew and drive tumor formation. The aim of this study was to identify and characterize a cancer ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000545

    authors: Feng D,Peng C,Li C,Zhou Y,Li M,Ling B,Wei H,Tian Z

    更新日期:2009-11-01 00:00:00

  • Cytokinetic analysis of cell cycle and sub-phases in MOLT-4 cells by cyclin E + A/DNA multiparameter flow cytometry.

    abstract::Cell cycle analysis has become increasingly important in verifying the effect of anti-tumor drugs and cytokinetic research. In the early methods of cell cycle analysis, the flow cytometry relied on DNA content, and therefore, the cell cycle could be only broken into three stages: G(0)/G(1), S, and G(2)/M phase. It cou...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Qin J,Tao D,Duan R,Leng Y,Shen M,Zhou H,Feng Y,Gao C,Yu Y,Li QQ,Hu J,Gong J

    更新日期:2002-09-01 00:00:00

  • Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.

    abstract::Prostate cancer is a leading cause of cancer-related death among men. Early diagnosis and treatment are successful against prostate cancer, yet the clinical treatment of advanced prostate cancer remains a challenge. Gemcitabine is used to treat a broad spectrum of solid tumors; however, the clinical response of prosta...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3696

    authors: Guo Z,Zhang X,Li X,Xie F,Su B,Zhang M,Zhou L

    更新日期:2015-03-01 00:00:00